Cannabis Law Report

AUGUST 20, 2022

CRCC’s paper, published by the Ohio State University (OSU) Moritz College of Law, is titled “Not a SAFE Bet: Equitable Access to Cannabis Banking, An Analysis of the SAFE Banking Act.”. Drug Enforcement and Policy Center, August, 2022. 21 Pages Posted: 12 Aug 2022. Date Written: August 11, 2022. Cat Packer.

Banking 52

Banking Access Research and Development Policy 52

Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. million patients in 2022, a sharp increase from the 3.1 million patients in 2022, a sharp increase from the 3.1 The study also analyzed peoples’ reasons for registering.

Patients 108

Patients Chronic Pain Marijuana Conditions 108

Cannabis Law Report

JANUARY 6, 2022

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52

Access Patients Therapy Conditions 52

MMJ Recs

JANUARY 15, 2022

Today, we’ll go through the process of how to get a medical marijuana card in Iowa in 2022. This changed in 2020, and Iowa now allows patients access to higher-THC preparations. The list of qualifying conditions for Iowa MMJ is relatively long and inclusive. So, how do I get my Iowa MMJ card in 2022? Yes, you can!

Chronic Pain 52

Chronic Pain Dispensary Conditions Programs 52

Cannabis Law Report

JANUARY 25, 2022

New York has decided to do away with its list of qualifying conditions for its medical cannabis program reports MJ Biz. The abolishment of qualifying conditions most likely will result in an increase in the number of registered medical marijuana patients and, therefore, could lead to a sales uptick for MMJ operators in New York.

Conditions 52

Conditions Programs Patients Access 52

Cannabis Law Report

AUGUST 20, 2022

Press Release – Friday, August 19, 2022. CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021.

Conditions 52

Conditions Dispensary Programs Business 52

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

SpeedWeed

SEPTEMBER 13, 2021

That news comes via AL.com , which said that the Alabama Medical Cannabis Commission has been in discussions with state legislators “about changing the date to allow cultivators to be licensed sooner, by no later than early 2022.”. The post Medical Marijuana Cultivators in Alabama to Start Planting in 2022 | appeared first on SpeedWeed.

Cultivation 90

Cultivation Marijuana Treatment Legislation 90

MMJ Recs

JANUARY 25, 2022

So now that medical marijuana is finally available in Ohio, how do you get an Ohio MMJ card in 2022? How Do I Get My Ohio MMJ Card In 2022? What Are The Qualifying Conditions For A Medical Card In Ohio In 2022? Image by 12019 on Pixabay : What are the qualifying conditions for a medical card in Ohio in 2022?

Dispensary 52

Dispensary Chronic Pain Programs Treatment 52

MMJ Recs

FEBRUARY 4, 2022

You can access all the MMJ products you need in the Sooner State’s many dispensaries using your OK MMJ card. If you’ve decided that this is the year you want to start using MMJ to alleviate your symptoms, read on for more information on how to get your Oklahoma MMJ card in 2022. The post How Do I Get My Oklahoma MMJ Card In 2022?

Conditions 52

Conditions Treatment Edibles Patients 52

Cannabis Law Report

AUGUST 22, 2022

MEDICAL MARIJUANA ACCESS AND PATIENT SAFETY, INC. August 22, 2022 (Harrisburg, PA) — Medical Marijuana Access and Patient Safety, Inc. August 22, 2022 (Harrisburg, PA) — Medical Marijuana Access and Patient Safety, Inc. Click on image to access Docs.

Safety 52

Safety Access Patients Marijuana 52

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. 27 September 2022. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Cannabis Law Report

SEPTEMBER 21, 2022

Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022. Reaffirms $150 to $170 Million in Annualized Cost Savings by December 31, 2022. Million in Q4 2022. 20, 2022 /PRNewswire/ – Aurora Cannabis Inc. (the of Aurora’s Q4 2022 consolidated net revenue 1 and 86.3%

Research and Development 52

Research and Development Cannabis Data Events 52

Cannabis Law Report

JULY 13, 2022

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. Compliance Priority. Deter and address the unlawful import, advertising and supply of unapproved therapeutic goods associated with COVID-19.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

Cannabis Law Report

FEBRUARY 11, 2022

Specifically, tension rose amongst the elected Democrats on whether to support incremental reform (like access to banks or removal of cannabis from the list of Schedule 1 drugs) or comprehensive legalization with provisions to address social inequities stemming from the legacy of the War on Drugs.

Banking 59

Banking Decriminalization Cannabis Programs 59

Veriheal

NOVEMBER 6, 2023

3% THC is legal for treating qualifying health conditions and even recreationally. THC was legalized for qualifying conditions. The Act aimed to provide patients access to smokable flower for 15 medical conditions. Possession of any quantity results in a misdemeanor for first-time offenders. In 2014, CBD with under 0.9%

Legalization 117

Legalization Recreational THC CBD 117

Veriheal

MARCH 20, 2023

While decriminalization decreases the negative impact of legal issues, it does not provide accessible, safe, and regulated psilocybin for those seeking treatment. Andy Smith (D) stated that he is “working on a bill forming a psychedelic medicine task force so Minnesotans can access these life-affirming treatments. Minnesota Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Canna Law Blog

JANUARY 25, 2023

With licenses issued and sales starting in 2022, New York got the ball rolling on an actual and legal cannabis industry. Let’s take a look at the noteworthy developments of 2022 and what we expect to see in 2023. Three big developments in 2022 1. More conditional cultivation and processing licenses have been issued since.

Dispensary 71

Dispensary Conditions Cultivation Retail 71

Cannabis Law Report

JANUARY 14, 2022

With a new year, comes a new legislative session, which started on January 10, 2022 here in Washington state. In Washington, we have short sessions (60 days) in even-numbered years and longer sessions (105 days) in odd-numbered years, so in 2022 there will be a short session. Limit youth access and youth exposure to cannabis.

Research and Development 52

Research and Development Cannabinoids Packaging Hemp 52

TheAnswerPage

MAY 16, 2022

A seizure disorder is a qualifying condition in many medical marijuana state programs. The effect of epidiolex (cannabidiol) on serum levels of concomitant anti-epileptic drugs in children and young adults with treatment-resistant epilepsy in an expanded access program. Friedman D, Cilio MR, Tilton N, et al. See the Answer.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Poland and cannabis. Can you grow your own weed?

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Cannabis Law Report

MAY 14, 2022

Momentum Builds in Senate for Passing SAFE Act – Bipartisan support in the Senate grows for passage of the SAFE Banking Act, which would facilitate banking access for cannabis companies. The program was officially adopted during the 2022 legislative session. Medical/Health.

Banking 52

Banking Recreational Research and Development Cannabis 52

Veriheal

SEPTEMBER 7, 2022

On July 6, 2022, Washington, D.C. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C. This 90-day amendment expired in May 2022; however, seniors retain the self-certification option through the emergency law now in effect. ’s Medical Cannabis Program. .’s Following Aug.

Patients 97

Patients Programs Access Treatment 97

Cannabis Law Report

JANUARY 11, 2022

(together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2021 (“Q1 Fiscal 2022”). While we previously projected to achieve positive adjusted EBITDA in Q4, with the purchase of Laurentian that will be accelerated to Q3 Fiscal 2022.”

Research and Development 52

Research and Development Cannabinoids Hash Cultivation 52

SpeedWeed

JULY 13, 2021

Henry McMaster, 74, in the November 2022 election. It would be a game-changer for people in South Carolina with debilitating health conditions. The post Group of Senators Say Cannabis Businesses Should Be Allowed to Access SBA Loans appeared first on SpeedWeed. During his two years in Washington, D.C., View original article.

Access 52

Access Business Data Legalization 52

Veriheal

NOVEMBER 7, 2023

The petition was first submitted in January 2022, with lawmakers given four months to act. Other lawmakers also claimed that the petition signatures were the reason the petition couldn’t make the ballot in 2022. Republican legislators voiced their intention to not vote the bill into law.

Legalization 120

Legalization Legislation Programs Recreational 120

Cannabis Law Report

JANUARY 20, 2022

19 January 2022. Emergency access to restricted drugs has been restored by recent regulatory amendments to Health Canada’s Special Access Program (SAP). SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient.

Access 52

Access Programs Treatment Therapy 52

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. In 2015, Georgia legalized possession of up 20 fl.

Law 96

Law Decriminalization Programs Patients 96

Cannabis Law Report

DECEMBER 21, 2021

Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. It’s also initiating phase 2a clinical trial into conditions such as eating disorders and fibromyalgia.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

MMJ Recs

JANUARY 20, 2024

Qualifying Conditions for Medical Marijuana in Maryland Maryland’s medical marijuana program, overseen by the Maryland Cannabis Administration , prioritizes patients with specific qualifying conditions, recognizing the therapeutic potential of cannabis.

Law 52

Law Marijuana Patients Chronic Pain 52

The Cannigma

SEPTEMBER 15, 2022

The state does allow qualifying patients to access CBD oil with no more than 0.9% Despite overwhelming support from state residents ( 81% of residents think cannabis should be legal in some capacity) multiple bills in 2022 and 2021 to legalize medical marijuana have failed. Tennessee does not have legal medical or adult-use cannabis.

Law 89

Law Oil Programs Hemp 89

SpeedWeed

JULY 23, 2021

The next step is to get FDA approval on human trials, which Small-Howard hopes will be in 2022 for the Parkinson’s formulation and shortly thereafter for the pain management drug. We really feel there are certainly lots of responsible players that are allowing patients to have access to cannabis-based products through state programs.

Research and Development 52

Research and Development Legalization Medicine Chronic Pain 52

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. As of June 2022, there is no way for medical patients to obtain a cannabis prescription or get medication. Possible penalties for cannabis.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Veriheal

MARCH 6, 2024

The HSS found strong scientific support regarding cannabis’ medically beneficial effects for conditions like anorexia , nausea, and chronic pain. The HSS also pointed out studies with weaker evidence suggesting cannabis can potentially help with conditions like PTSD , epilepsy , and anxiety.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

The Cannigma

NOVEMBER 3, 2022

Patients with qualifying conditions, including cancer, multiple sclerosis, epilepsy, and HIV/AIDS can access cannabis-derived medicines with a prescription. As of July 2022, at least one publication reported no patients have access to cannabis medicine. CBD regulations. THC or less.

Law 59

Law Decriminalization Programs Hemp 59